Abdel Moneim LM, Helmy MW, El-Abhar HS. Co-targeting of endothelin-(A) and vitamin D receptors: a novel strategy to ameliorate cisplatin-induced nephrotoxicity. Pharmacol Rep. 2019;71(5):917-25.

Karra P, Winn M, Pauleck S, et al. Metabolic dysfunction and obesity-related cancer: beyond obesity and metabolic syndrome. Obesity (Silver Spring, Md). 2022;30(7):1323-34.

Ritz E, Rychlík I, Locatelli F, Halimi S. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis. 1999;34(5):795-808.

Jung CY, Yoo TH. Pathophysiologic mechanisms and potential biomarkers in diabetic kidney disease. Diabetes Metab J. 2022;46(2):181-97.

Scilletta S, Di Marco M, Miano N, et al. Update on diabetic kidney disease (DKD): Focus on non-albuminuric DKD and cardiovascular risk. Biomolecules. 2023;13(5).

Liu WJ, Huang WF, Ye L, et al. The activity and role of autophagy in the pathogenesis of diabetic nephropathy. Eur Rev Med Pharmacol Sci. 2018;22(10):3182-9.

Kitada M, Ogura Y, Monno I, Koya D. Regulating autophagy as a therapeutic target for diabetic nephropathy. Curr Diab Rep. 2017;17(7):53.

Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: Metabolism, molecular mechanism of action, and pleiotropic effects. Physiological Reviews. 2016;96(1):365-408.

Bouillon R, Marcocci C, Carmeliet G, et al. Skeletal and extraskeletal actions of vitamin D: Current evidence and outstanding questions. Endocrine Reviews. 2019;40(4):1109-51.

Galuška D, Pácal L, Kaňková K. Pathophysiological implication of vitamin D in diabetic kidney disease. Kidney & blood pressure research. 2021;46(2):152-61.

Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92(1):4-8.

Andress DL. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney International. 2006;69(1):33- 43.

Yang S, Li A, Wang J, et al. Vitamin D receptor: a novel therapeutic target for kidney diseases. Curr Med Chem. 2018;25(27):3256-71.

Pike JW, Meyer MB, Lee SM, Onal M, Benkusky NA. The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights. J Clin Invest. 2017;127(4):1146-54.

Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16(7):377-90.

Lei M, Liu Z, Guo J. The emerging role of vitamin D and vitamin D receptor in diabetic nephropathy. Biomed Res Int. 2020;2020:4137268.

Wang H, Yu X, Liu D, et al. VDR activation attenuates renal tubular epithelial cell ferroptosis by regulating Nrf2/HO-1 signaling pathway in diabetic nephropathy. Adv Sci (Weinh). 2024;11(10):e2305563.

Tsur A, Feldman BS, Feldhammer I, Hoshen MB, Leibowitz G, Balicer RD. Decreased serum concentrations of 25-hydroxycholecalciferol are associated with an increased risk of progression to impaired fasting glucose and diabetes. Diabetes Care. 2013;36(5):1361-7.

Wang Y, Yang S, Zhou Q, Zhang H, Yi B. Effects of vitamin D supplementation on renal function, inflammation and glycemic control in patients with diabetic nephropathy: A systematic review and meta-analysis. Kidney & blood pressure research. 2019;44(1):72-87.

Huang HY, Lin TW, Hong ZX, Lim LM. Vitamin D and diabetic kidney disease. Int J Mol Sci. 2023;24(4).

Taderegew MM, Woldeamanuel GG, Wondie A, Getaway A, Abegaz AN, Adane F. Vitamin D deficiency and its associated factors among patients with type 2 diabetes mellitus: a systematic review and meta-analysis. BMJ open. 2023;13(10):e075607.

Kadowaki S, Norman AW. Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest. 1984;73(3):759-66.

Karnchanasorn R, Ou HY, Chiu KC. Plasma 25-hydroxyvitamin D levels are favorably associated with β-cell function. Pancreas. 2012;41(6):863-8.

Bornstedt ME, Gjerlaugsen N, Pepaj M, Bredahl MKL, Thorsby PM. Vitamin D increases glucose stimulated insulin secretion by insulin producing beta cells (INS1E). Int J Endocrinol Metab. 2019;17(1):e74255.

Wimalawansa SJ. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome. J Steroid Biochem Mol Biol. 2018;175:177-89.

Hosseini ES, Kashani HH, Nikzad H, et al. Diabetic hemodialysis: Vitamin D supplementation and its related signaling pathways involved in insulin and lipid metabolism. Curr Mol Med. 2019;19(8):570-8.

Lemieux P, Weisnagel SJ, Caron AZ, et al. Effects of 6-month vitamin D supplementation on insulin sensitivity and secretion: a randomized, placebo-controlled trial. Eur J Endocrinol. 2019;181(3):287-99.

Samsu N. Diabetic nephropathy: Challenges in pathogenesis, diagnosis, and treatment. Biomed Res Int. 2021;2021:1497449.

Navarro JF, Mora C. Role of inflammation in diabetic complications. Nephrol Dial Transplant. 2005;20(12):2601-4.

Royall JA, Berkow RL, Beckman JS, Cunningham MK, Matalon S, Freeman BA. Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability. Am J Physiol. 1989;257(6 Pt 1): L399-410.

Melcion C, Lachman L, Killen PD, Morel-Maroger L, Striker GE. Mesangial cells, the effect of monocyte products on proliferation and matrix synthesis. Transplant Proc. 1982;14(3):559-64.

Dalla Vestra M, Mussap M, Gallina P, et al. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J Am Soc Nephrol. 2005;16 Suppl 1:S78-82.

Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today. 1990;11(12):443-9.

Donate-Correa J, Ferri CM, Sánchez-Quintana F, et al. Inflammatory cytokines in diabetic kidney disease: pathophysiologic and therapeutic implications. Front Med (Lausanne). 2020;7:628289.

Lee S, Huen S, Nishio H, et al. Distinct macrophage phenotypes contribute to kidney injury and repair. j Am Soc Nephrol. 2011;22(2):317-26.

Hu X, Liu W, Yan Y, et al. Vitamin D protects against diabetic nephropathy: Evidence-based effectiveness and mechanism. Eur J Pharmacol. 2019;845:91-8.

Zhang X, Zhao Y, Zhu X, et al. Active vitamin D regulates macrophage M1/M2 phenotypes via the STAT-1-TREM-1 pathway in diabetic nephropathy. j Cell Physiol. 2019;234(5):6917-26.

Zhang XL, Guo YF, Song ZX, Zhou M. Vitamin D prevents podocyte injury via regulation of macrophage M1/M2 phenotype in diabetic nephropathy rats. Endocrinology. 2014;155(12):4939-50.

Fu H, Liu S, Bastacky SI, Wang X, Tian XJ, Zhou D. Diabetic kidney diseases revisited: a new perspective for a new era. Mol Metab. 2019;30:250-63.

Xu L, Zhang P, Guan H, et al. Vitamin D and its receptor regulate lipopolysaccharide-induced transforming growth factor-β, angiotensinogen expression, and podocyte apoptosis through the nuclear factor-κB pathway. J Diabetes Investig. 2016;7(5):680-8.

Deb DK, Wang Y, Zhang Z, et al. The molecular mechanism underlying 1,25-dihydroxyvitamin D regulation of nephrin gene expression. J Biol Chem. 2011;286(37):32011-7.

Trohatou O, Tsilibary EF, Charonis A, Iatrou C, Drossopoulou G. Vitamin D3 ameliorates podocyte injury through the nephrin signaling pathway. j Cell Mol Med. 2017;21(10):2599-609.

Shi L, Xiao C, Zhang Y, et al. Vitamin D/vitamin D receptor/Atg16L1 axis maintains podocyte autophagy and survival in diabetic kidney disease. Ren Fail. 2022;44(1):694-705.

Gnudi L, Coward RJM, Long DA. Diabetic nephropathy: Perspective on novel molecular mechanisms. Trends in Endocrinology and Metabolism: TEM. 2016. 27(11):820-30.

Lin L, Phillips WE, Manning RD. Intrarenal Angiotensin ii is associated with inflammation, renal damage, and dysfunction in dahl salt-sensitive hypertension. J Am Soc Hypertens. 2009;3(5):306-14.

Riera M, Anguiano L, Clotet S, et al. Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria. Am J Physiol Renal Physiol. 2016;310(6):F534-46.

Eltablawy N, Ashour H, Rashed LA, Hamza WM. Vitamin D protection from rat diabetic nephropathy is partly mediated through Klotho expression and renin-angiotensin inhibition. Arch Physiol Biochem. 2018;124(5):461-7.

fine LG, Norman JT. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney international. 2008;74(7):867-72.

Chen H, Zhang H, Li AM, et al. VDR regulates mitochondrial function as a protective mechanism against renal tubular cell injury in diabetic rats. Redox Biol. 2024;70:103062.

Zhang Z, Sun L, Wang Y, et al. Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney international. 2008;73(2):163-71.

Manucha W, Juncos LI. The protective role of vitamin D on the heart and the kidney. Ther Adv Cardiovasc Dis. 2017;11(1):12-9.

Zhang Y, Kong J, Deb DK, Chang A, Li YC. Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system. J Am Soc Nephrol. 2010;21(6):966-73.

Chen X, Wan Z, Geng T, et al. Vitamin D status, vitamin D receptor polymorphisms, and risk of microvascular complications among individuals with type 2 diabetes: a prospective study. Diabetes Care. 2023;46(2):270-7.

Zhong P, Zhu Z, Wang Y, Huang W, He M, Wang W. Cardiovascular and microvascular outcomes according to vitamin D level and genetic variants among individuals with prediabetes: a prospective study. J Transl Med. 2023;21(1):724.

Deb DK, Sun T, Wong KE, et al. Combined vitamin D analog and AT1 receptor antagonists synergistically block the development of kidney disease in a model of type 2 diabetes. Kidney International. 2010;77(11):1000-9.

Qu Y, Wu Y, Jiang H. Research progress in the pharmacological actions of the multiple effects and selectivity of the vitamin D analog paricalcitol: a narrative review. Ann Palliat Med. 2021;10(10):11177-90.

Nakhoul N, Thawko T, Farber E, et al. The therapeutic effect of active vitamin d supplementation in preventing the progression of diabetic nephropathy in a diabetic mouse model. J Diabetes Res. 2020;2020:7907605.

Sözel H, Köksoy S, Ozdem S, Yılmaz F, Bora F, Ersoy FF. Lymphocyte and monocyte vitamin D receptor expression during paricalcitol or calcitriol treatments in patients with stage 5 chronic kidney disease. Int Urol Nephrol. 2020;52(8):1563-70.

Zeng JY, Wang Y, Hong FY, et al. Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of the VDR/Wnt/β-catenin pathway in rats with diabetic nephropathy. Naunyn Schmiedebergs Arch Pharmacol. 2023.

Humalda JK, Goldsmith DJ, Thadhani R, de Borst MH. Vitamin D analogs to target residual proteinuria: potential impact on cardiorenal outcomes. Nephrol Dial Transplant. 2015;30(12):1988-94.

Freundlich M, Gamba G, Rodriguez-Iturbe B. Fibroblast growth factor 23-Klotho and hypertension: experimental and clinical mechanisms. Pediatr Nephrol. 2021;36(10):3007-22.

Jacobus CH, Holick MF, Shao Q, et al. Hypervitaminosis D is associated with drinking milk. N Engl J Med. 1992;326(18):1173-7.

Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol. 2008;3(5):1535-41.

Akcay A, Ozdemir FN, Sezer S, et al. Association of vitamin D receptor gene polymorphisms with hypercalcemia in peritoneal dialysis patients. Perit Dial Int. 2005;25 Suppl 3:S52-5.

Wu CC, Liao MT, Hsiao PJ, et al. Antiproteinuria effect of calcitriol in patients with chronic kidney disease and vitamin d deficiency: A randomized controlled study. J Ren Nutr. 2020;30(3):200-7.

Bilezikian JP, Formenti AM, Adler RA, et al. Vitamin D: Dosing, levels, form, and route of administration. Does one approach fit all? Rev Endocr Metab Disord. 2021;22(4):1201-18.

Thadhani R, Appelbaum E, Pritchett Y, et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. Jama. 2012;307(7):674-84.

de Zeeuw D, Agarwal R, Amdahl M, et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomized controlled trial. Lancet. 2010;376(9752):1543-51.

Li C, Ojeda-Thies C, Renz N, Margaryan D, Perka C, Trampuz A. The global state of clinical research and trends in periprosthetic joint infection: a bibliometric analysis. Int J Infect Dis. 2020;96:696-709.

Ke L, Lu C, Shen R, Lu T, Ma B, Hua Y. Knowledge mapping of drug-induced liver injury: a scientometric investigation (2010-2019). Front Pharmacol. 2020;11:842.

van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523-38.

Yeung AWK, Mozos I. The innovative and sustainable use of dental panoramic radiographs for the detection of osteoporosis. Int J Environ Res Public Health. 2020;17(7).

Zhang XL, Zheng Y, Xia ML, et al. Knowledge domain and emerging trends in vinegar research: a bibliometric review of the literature from WoSCC. Foods. 2020;9(2).

Synnestvedt MB, Chen C, Holmes JH. CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc. 2005;2005:724-8.

Huang X, Fan X, Ying J, Chen S. Emerging trends and research foci in the gastrointestinal microbiome. J Transl Med. 2019;17(1):67.